Literature DB >> 24833708

Biological functional annotation of retinoic acid alpha and beta in mouse liver based on genome-wide binding.

Yuqi He1, Jessica Tsuei1, Yu-Jui Yvonne Wan2.   

Abstract

Retinoic acid (RA) has diverse biological effects. The liver stores vitamin A, generates RA, and expresses receptors for RA. The current study examines the hepatic binding profile of two RA receptor isoforms, RARA (RARα) and RARB (RARβ), in response to RA treatment in mouse livers. Our data uncovered 35,521, and 14,968 genomic bindings for RARA and RARB, respectively. Each expressed unique and common bindings, implying their redundant and specific roles. RARB has higher RA responsiveness than RARB. RA treatment generated 18,821 novel RARB bindings but only 14,798 of RARA bindings, compared with the control group. RAR frequently bound the consensus hormone response element [HRE; (A/G)G(G/T)TCA], which often contained the motifs assigned to SP1, GABPA, and FOXA2, suggesting potential interactions between those transcriptional factors. Functional annotation coupled with principle component analysis revealed that the function of RAR target genes were motif dependent. Taken together, the cistrome of RARA and RARB revealed their extensive biological roles in the mouse liver. RAR target genes are enriched in various biological processes. The hepatic RAR genome-wide binding data can help us understand the global molecular mechanisms underlying RAR and RA-mediated gene and pathway regulation.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  ChIP-Seq; cistrome; liver; motif; retinoic acid

Mesh:

Substances:

Year:  2014        PMID: 24833708      PMCID: PMC4101682          DOI: 10.1152/ajpgi.00105.2014

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  44 in total

1.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.

Authors:  Da Wei Huang; Brad T Sherman; Richard A Lempicki
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

2.  Genomic antagonism between retinoic acid and estrogen signaling in breast cancer.

Authors:  Sujun Hua; Ralf Kittler; Kevin P White
Journal:  Cell       Date:  2009-06-26       Impact factor: 41.582

3.  Cell-specific interaction of retinoic acid receptors with target genes in mouse embryonic fibroblasts and embryonic stem cells.

Authors:  Laurence Delacroix; Emmanuel Moutier; Gioia Altobelli; Stephanie Legras; Olivier Poch; Mohamed-Amin Choukrallah; Isabelle Bertin; Bernard Jost; Irwin Davidson
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

4.  PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia.

Authors:  Joost H A Martens; Arie B Brinkman; Femke Simmer; Kees-Jan Francoijs; Angela Nebbioso; Felicetto Ferrara; Lucia Altucci; Hendrik G Stunnenberg
Journal:  Cancer Cell       Date:  2010-02-17       Impact factor: 31.743

5.  Retinoic acid treatment enhances lipid oxidation and inhibits lipid biosynthesis capacities in the liver of mice.

Authors:  Jaume Amengual; Joan Ribot; M Luisa Bonet; Andreu Palou
Journal:  Cell Physiol Biochem       Date:  2010-05-18

6.  Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer.

Authors:  Caryn S Ross-Innes; Rory Stark; Kelly A Holmes; Dominic Schmidt; Christiana Spyrou; Roslin Russell; Charlie E Massie; Sarah L Vowler; Matthew Eldridge; Jason S Carroll
Journal:  Genes Dev       Date:  2010-01-15       Impact factor: 11.361

7.  Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine.

Authors:  Ann M Thomas; Steven N Hart; Bo Kong; Jianwen Fang; Xiao-Bo Zhong; Grace L Guo
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

8.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.

Authors:  Ben Langmead; Cole Trapnell; Mihai Pop; Steven L Salzberg
Journal:  Genome Biol       Date:  2009-03-04       Impact factor: 13.583

9.  RXR-dependent and RXR-independent transactivation by retinoic acid receptors.

Authors:  M Schräder; A Wyss; L J Sturzenbecker; J F Grippo; P LeMotte; C Carlberg
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

10.  Model-based analysis of ChIP-Seq (MACS).

Authors:  Yong Zhang; Tao Liu; Clifford A Meyer; Jérôme Eeckhoute; David S Johnson; Bradley E Bernstein; Chad Nusbaum; Richard M Myers; Myles Brown; Wei Li; X Shirley Liu
Journal:  Genome Biol       Date:  2008-09-17       Impact factor: 13.583

View more
  4 in total

1.  Dysregulated bile acid synthesis and dysbiosis are implicated in Western diet-induced systemic inflammation, microglial activation, and reduced neuroplasticity.

Authors:  Prasant Kumar Jena; Lili Sheng; Jacopo Di Lucente; Lee-Way Jin; Izumi Maezawa; Yu-Jui Yvonne Wan
Journal:  FASEB J       Date:  2018-01-10       Impact factor: 5.191

2.  RDH1 suppresses adiposity by promoting brown adipose adaptation to fasting and re-feeding.

Authors:  Charles R Krois; Marta G Vuckovic; Priscilla Huang; Claire Zaversnik; Conan S Liu; Candice E Gibson; Madelyn R Wheeler; Kristin M Obrochta; Jin H Min; Candice B Herber; Airlia C Thompson; Ishan D Shah; Sean P Gordon; Marc K Hellerstein; Joseph L Napoli
Journal:  Cell Mol Life Sci       Date:  2019-02-20       Impact factor: 9.261

3.  RARβ acts as both an upstream regulator and downstream effector of miR-22, which epigenetically regulates NUR77 to induce apoptosis of colon cancer cells.

Authors:  Ying Hu; Samuel W French; Thinh Chau; Hui-Xin Liu; Lili Sheng; Fang Wei; Jesse Stondell; Juan C Garcia; Yanlei Du; Christopher L Bowlus; Yu-Jui Yvonne Wan
Journal:  FASEB J       Date:  2018-09-25       Impact factor: 5.191

4.  Retinoids Issued from Hepatic Stellate Cell Lipid Droplet Loss as Potential Signaling Molecules Orchestrating a Multicellular Liver Injury Response.

Authors:  Marie Bobowski-Gerard; Francesco Paolo Zummo; Bart Staels; Philippe Lefebvre; Jérôme Eeckhoute
Journal:  Cells       Date:  2018-09-13       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.